Wanbury gets nod to settle debt by selling few brands
03 Jun 2019
Wanbury has received approval for debt settlement and fund raising plan by sale of few brands. The Board of Directors of the Company at its meeting held on June 01, 2019 has approved the same.
Wanbury is the fastest growing pharma company and has a strong presence in the domestic branded formulations.
Related Wanbury Ltd. Links:
37.35
1.75 (4.92%)
Aug 07, 18:01
1 Year Price Chart
Peers
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 525.80 |
| Dr. Reddys Lab | 4571.25 |
| Lupin | 879.40 |
| Piramal Enterprises | 1464.35 |
| Cadila Healthcare | 390.70 |
| View more.. | |
Sensex vs Wanbury
